Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSenti Biosciences Holdings, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Senti Biosciences Holdings, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $17K. Net result −$12.75M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $17K. Running result $17K. Revenue: $17K.
  • Cost of revenue: $0. Running result $17K.
  • Gross profit: $17K. Running result $17K.
  • Research and development (including related party costs of $3,516 and $3,586 for the three months ended June 30, 2026 and 2025, respectively, and $3,798 and $7,656 for the six months ended June 30, 2026 and 2025, respectively): −$7.77M. Running result −$7.75M.
  • General and administrative: −$6.74M. Running result −$14.49M.
  • Gain on lease modification: $0. Running result −$14.49M.
  • Operating income: −$14.49M. Running result −$14.49M.
  • Other income: $1.74M. Running result −$12.75M.
  • Pre-tax loss: −$12.75M. Running result −$12.75M.
  • Income tax benefit: $0. Running result −$12.75M.
  • Net loss: −$12.75M. Running result −$12.75M.